EZH2 directly methylates PARP1 and regulates its activity in cancer
Qingshu Meng,Jiangchuan Shen,Yanan Ren,Qi Liu,Rui Wang,Qiaqia Li,Weihua Jiang,Quan Wang,Yixiang Zhang,Jonathan C. Trinidad,Xiaotong Lu,Tingyou Wang,Yanqiang Li,Chaehyun Yum,Yang Yi,Yongyong Yang,Dongyu Zhao,Clair Harris,Sundeep Kalantry,Kaifu Chen,Rendong Yang,Hengyao Niu,Qi Cao
DOI: https://doi.org/10.1126/sciadv.adl2804
IF: 13.6
2024-11-28
Science Advances
Abstract:DNA repair dysregulation is a key driver of cancer development. Understanding the molecular mechanisms underlying DNA repair dysregulation in cancer cells is crucial for cancer development and therapies. Here, we report that enhancer of zeste homolog 2 (EZH2) directly methylates poly(adenosine diphosphate–ribose) polymerase-1 (PARP-1), an essential enzyme involved in DNA repair, and regulates its activity. Functionally, EZH2-catalyzed methylation represses PARP1 catalytic activity, down-regulates the recruitment of x-ray repair cross-complementing group-1 to DNA lesions and its associated DNA damage repair; on the other hand, it protects the cells from nicotinamide adenine dinucleotide overconsumption upon DNA damage formation. Meanwhile, EZH2-mediated methylation regulates PARP1 transcriptional and oncogenic activity, at least in part, through impairing PARP1-E2F1 interaction and E2F1 transcription factor activity. EZH2 and PARP1 inhibitors synergistically suppress prostate cancer growth. Collectively, our findings uncover an insight of EZH2 functions in fine-tuning PARP1 activity during DNA damage repair and cancer progression, which provides a rationale for combinational targeting EZH2 and PARP1 in cancer.
multidisciplinary sciences